Who
John S. McBride
Director
Company insider
Files Form 4 as: Chief Operating Officer, Eledon Pharmaceuticals.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $315K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Oct 2014
- Last trade
- 10 Jan 2026
- Last filed
- 16 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2026filed 16 Jan 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,430 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,870 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,430 at $0.00 | filing |
| 1 May 2023filed 2 May 2023 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,437 at $0.00 | filing |
| 1 Feb 2023filed 2 Feb 2023 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Feb 2022filed 2 Feb 2022 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 11 Sep 2020filed 15 Sep 2020 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,167.21 at $0.00 | filing |
| 11 Jul 2019filed 15 Jul 2019 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 13 Jun 2018filed 14 Jun 2018 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,100 at $0.00 | filing |
| 30 Jun 2017filed 5 Jul 2017 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 15 Dec 2015filed 17 Dec 2015 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,000 at $0.00 | filing |
| 21 Sep 2015filed 22 Sep 2015 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $57K13,500 at $4.19 | filing |
| 21 Sep 2015filed 22 Sep 2015 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $189K13,500 at $14.01 | filing |
| 21 Sep 2015filed 22 Sep 2015 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,500 at $0.00 | filing |
| 24 Jun 2015filed 24 Jun 2015 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $1,257300 at $4.19 | filing |
| 24 Jun 2015filed 24 Jun 2015 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,260300 at $14.20 | filing |
| 24 Jun 2015filed 24 Jun 2015 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —300 at $0.00 | filing |
News
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual MeetingELDN · manilatimes.net · 5 Oct 2026
0 headlines in the last 90 days name John S. McBride; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.